News
Which smartphone is worth paying around Rs.20000? The Vivo T4 5G or the new Oppo A5 Pro. Here’s a detailed comparison for a better understanding. The Oppo A5 Pro recently made its debut in India ...
Oppo K13 5G officially goes on sale in India at a starting price of just Rs.17999. Know in detail about storage variants, sale offers, availability, and more. Oppo K13 5G has been making waves in ...
OPPO has broadened its A-series smartphone portfolio in India with the launch of the OPPO A5 Pro 5G, a feature-packed mid-range device. With a starting price of ₹17,999, the smartphone boasts a ...
Oppo on Thursday (April 24, 2025) launched the Oppo A5 Pro 5G mid-ranger smartphone with IP69, IP68, and IP66 certifications for water and dust resistance. It is military standard certified as ...
Oppo A5 Pro 5G vs Vivo T4 5G: Oppo has recently launched the Oppo A5 Pro 5G in India, a mid-range smartphone designed to offer competitive features at an affordable price. It features a large 6.67 ...
Oppo has unveiled its latest smartphone in India, the Oppo A5 Pro, adding to its popular A Series lineup. This budget-friendly device comes in two configurations and is powered by a MediaTek ...
Oppo has introduced its new A5 Pro 5G in India. This device has two models, including an 8GB RAM + 128GB storage version as well as an 8GB RAM and 256GB storage model. It comes with a robust ...
Chinese smartphone maker has officially introduced the Oppo A5 Pro 5G in the Indian market. The Oppo A3 Pro successor comes with a series of upgrades including the design, specifications ...
A new budget smartphone from Oppo has just dropped in the Indian market. The model in question is the Oppo A5 Pro 5G, which arrives with a familiar yet durable design that is also waterproof.
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON” or the "Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin ...
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results